Evidence map›Paper›PMID 41511518›Full record

ArticlePediatric cardiology2026

Rapid Regression of Myocardial Hypertrophy with First-Line Avalglucosidase Alfa in Infantile-Onset Pompe Disease: A Case Report.

Natsumi Uemura, Mitsuhiro Fujino, Shinji Higuchi, Kae Nakamura, Takeshi Sasaki, Yuki Kawasaki, Jun Mori, Eiji Ehara, Hisashi Sugiyama

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Natsumi UemuraDepartment of Pediatric Cardiology and Electrophysiology, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Mitsuhiro FujinoDepartment of Pediatric Cardiology and Electrophysiology, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan. m-fujino@med.osakacity-hp.or.jp.
Shinji HiguchiDivision of Pediatric Endocrinology and Metabolism, Osaka City, Japan.
Kae NakamuraDepartment of Pediatric Cardiology and Electrophysiology, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Takeshi SasakiDepartment of Pediatric Cardiology and Electrophysiology, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Yuki KawasakiDepartment of Pediatric Cardiology and Electrophysiology, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Jun MoriDivision of Pediatric Endocrinology and Metabolism, Osaka City, Japan.
Eiji EharaDepartment of Pediatric Cardiology and Electrophysiology, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Hisashi SugiyamaDepartment of Pediatric Cardiology and Electrophysiology, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A male infant born at 38 weeks of gestation was found to have myocardial hypertrophy on neonatal screening echocardiography, with a left ventricular mass index (LVMI) of 102.1 g/m

Indexed as

Avalglucosidase alfaInfantile-onset pompe diseaseMyocardial hypertrophy

Identifiers

PMID41511518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.